VYT — Vytrus Biotech SA Cashflow Statement
0.000.00%
Last trade - 00:00- €120.26m
- €118.06m
- €8.37m
Annual cashflow statement for Vytrus Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.309 | 0.453 | 0.308 | 0.902 | 3.13 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.486 | -0.503 | 0.237 | 0.201 | 0.238 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.049 | -0.416 | -0.366 | -0.089 | -0.439 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.448 | 0.226 | 0.904 | 1.84 | 3.9 |
| Capital Expenditures | -0.272 | -0.494 | -1.17 | -1.2 | -2.68 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.031 | -0.032 | -0.015 | 0 | -0.081 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.303 | -0.526 | -1.18 | -1.2 | -2.76 |
| Financing Cash Flow Items | -0.075 | — | — | 0.043 | 0.221 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.045 | -0.258 | 0.657 | 0.783 | -0.292 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.19 | -0.559 | 0.38 | 1.42 | 0.848 |